Company intelligence
DIAMED Medizintechnik GmbH
Passion and know-how for health
About DIAMED Medizintechnik GmbH
We are a team of specialists, primarily natural scientists and engineers, fully committed to offer our customers overall support regarding the application and use of our products. We are your partner, whether your questions on extracorporeal blood purification are of technical or scientific nature. Our experienced medical product experts have been working with us for many years, ensuring reliability and continuity in our relationships with you, our customers. Enhancing life is – and always has been – our motivation for 50 years now. Together with our Japanese partner Asahi Kasei Medical, we offer equipment technology, filters, adsorbers, and other high-quality medical devices for the German-speaking areas of Europe. The Octo Nova therapeutic device, developed by us and manufactured in Germany, as well as the new Japanese Plasauto SIGMA equipment technology, offer the highest level of versatility and engineering excellence. As a medium-sized German company, we are very flexible and fast. We support and take care of our customers, physicians, and their patients – even in the event of acute incidents. Thanks to close cooperations with our satisfied customers, we have become one of the most reputable specialists in various fields of extracorporeal blood purification which makes us very proud. At the same time, we have an ongoing commitment to constantly work on the further development of new therapies and treatment options.
Verified activity
Signals from DIAMED Medizintechnik GmbH
6 published signals
Research & Knowledge
DIAMED Medizintechnik GmbH reports on the BR-350 adsorbent removing bilirubin, gallium, and aromatic amino acids from plasma.
Reported by DIAMED Medizintechnik GmbH
Research & Knowledge
DIAMED Medizintechnik GmbH published a video interview featuring Prof. Hönemann on the application of HematoPure Duo in the daily routine of intensive care units.
Reported by DIAMED Medizintechnik GmbH
Research & Knowledge
DIAMED Medizintechnik GmbH published top line results from the Pelacarsen HORIZON outcome trial, which showed that the regular lipoprotein aporesis study group could reduce cardiovascular events significantly compared to placebo.
Reported by Joachim Seyfang
Research & Knowledge
DIAMED Medizintechnik GmbH published a study showing Plasma-Adsorptions-Perfusion (PAP/Leberpherese) using anion exchange adsorbers in comparison to open albumindialysis (OPAL) for extracorporeal liver support.
Reported by DIAMED Medizintechnik GmbH
Research & Knowledge
DIAMED Medizintechnik GmbH published a video interview featuring Prof. Hönemann on the optimal time window and criteria for the use of HematoPure Duo in intensive care.
Reported by DIAMED Medizintechnik GmbH
Research & Knowledge
DIAMED Medizintechnik GmbH published a study by Schwake et al. in J Neurol Neurosurg Psychiatry on the NEMOS-Netzwerk regarding the use of Apherese in MOGAD patients.
Reported by DIAMED Medizintechnik GmbH